文献速递冠心病外科

杂交冠状动脉血运重建与体外循环冠状动脉旁路移植术的比较

Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting.
PubMed 文献 · Ann Thorac Surg · 2018-03-20

本研究比较了本机构2004年3月至2015年11月间所有体外循环冠状动脉旁路移植术(CABG,n=682)与杂交冠状动脉血运重建(HCR,n=147)患者,采用倾向性评分逆概率加权调整分析。调整后,HCR与较低的院内死亡率(CABG 1.3% vs HCR 0%,p=0.008)和较短的平均住院时间(CABG 6.7±4.7天 vs HCR 4.5±2.1天,p<0.001)相关,随访中HCR在免于心绞痛方面更优(CABG 70% vs HCR 91%,p<0.001),生存率和免于再次血运重建无显著差异。

要点

  • 调整后HCR与CABG在再探查止血、围术期心肌梗死、卒中、血液透析、输血、延长机械通气和ICU住院时间方面无显著差异。
  • HCR与较低的院内死亡率相关(CABG 1.3% vs HCR 0%,p=0.008),平均住院时间更短(CABG 6.7±4.7天 vs HCR 4.5±2.1天,p<0.001)。
  • 中位随访期间,HCR在免于心绞痛方面优于CABG(CABG 70% vs HCR 91%,p<0.001),生存率和免于再次血运重建无显著差异。

核心结论

  • 对于经过选择的患者,与标准体外循环CABG相比,HCR与更快的术后恢复相关,短期和长期结局相似。

研究设计与样本

  • 纳入本机构2004年3月至2015年11月间所有体外循环CABG(n=682)和HCR(n=147,机器人辅助微创左胸廓内动脉至左前降支旁路移植加非左前降支血管经皮冠状动脉介入治疗)。
  • 采用基于倾向性评分的逆概率加权进行校正分析。

主要发现

  • 校正分析中,再探查止血、围术期心肌梗死、卒中、血液透析需求、输血率、延长机械通气和ICU住院时间无统计学显著差异。
  • HCR与较低的院内死亡率相关(CABG 1.3% vs HCR 0%,p=0.008)。
  • HCR与较短的平均住院时间相关(CABG 6.7±4.7天 vs HCR 4.5±2.1天,p<0.001)。
  • CABG组中位随访70个月(范围37至106),HCR组中位随访96个月(范围53至114),生存率无显著差异(CABG 92% vs HCR 97%,p=0.13),免于任何形式血运重建无显著差异(CABG 93% vs HCR 91%,p=0.27)。
  • HCR在免于心绞痛方面更优(CABG 70% vs HCR 91%,p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hybrid coronary revascularization (HCR) is an evolving coronary revascularization strategy for the treatment of multivessel coronary artery disease. We provide a comparative analysis to conventional on-pump coronary artery bypass graft surgery (CABG) with long-term follow-up. METHODS: We included all double on-pump CABG (n = 682) and HCR (147 robotic-assisted minimally invasive bypass grafts of the left internal thoracic artery to the left anterior descending coronary artery and percutaneous coronary intervention to one of the non-left anterior descending coronary artery vessels) performed in our institution between March 2004 and November 2015. We performed an adjusted analysis using inverse-probability weighting based on the propensity score of receiving either on-pump CABG or HCR. RESULTS: In the adjusted analysis, there was no statistically significant difference in the incidence of reexploration for bleeding, perioperative myocardial infarction, stroke, need for hemodialysis, blood transfusion rate, prolonged mechanical ventilation, and intensive care unit length of stay. Hybrid coronary revascularization was associated with lower inhospital mortality (CABG 1.3%, HCR 0%, p = 0.008), and shorter mean (± SD) hospital length of stay (CABG 6.7 ± 4.7 days, HCR 4.5 ± 2.1 days, p < 0.001). After a median follow-up period of 70 months (range, 37 to 106) for the CABG group and 96 months (range, 53 to 114) for the HCR group, there was no significant difference in survival (CABG 92%, HCR 97%, p = 0.13) or freedom from any form of revascularization (CABG 93%, HCR 91%, p = 0.27). Hybrid coronary revascularization was superior in freedom from angina (CABG 70%, HCR 91%, p < 0.001). CONCLUSIONS: For selected patients, HCR is associated with a faster postoperative recovery as well as similar short-term and long-term outcomes when compared with standard on-pump CABG.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Giambruno V, Jones P, Khaliel F, et al. Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting. Ann Thorac Surg. 2018. PMID: 29571730. doi:10.1016/j.athoracsur.2017.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。